The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 17:405-412, August 2005
doi: 10.1176/appi.neuropsych.17.3.405
© 2005 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Schwartz, J. R.L.
* Articles by Bogan, R. K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Schwartz, J. R.L.
* Articles by Bogan, R. K.
Related Collections
* Other Neuropsychiatric Disorders

Dose Effects of Modafinil in Sustaining Wakefulness in Narcolepsy Patients With Residual Evening Sleepiness

Jonathan R.L. Schwartz, M.D., Neil T. Feldman, M.D. and Richard K. Bogan, M.D.

Received October 8, 2003; revised May 6, 2004; accepted May 7, 2004. From the Integris Southwest and Baptist Medical Centers, Oklahoma City, Oklahoma; Palms of Pasadena Hospital, St. Petersburg, Florida; and the Baptist Medical Center, Columbia, South Carolina. Address correspondence to Dr. Schwartz, Integris Sleep Disorders Center of Oklahoma, Integris Southwest and Baptist Medical Centers, 4200 S. Douglas, Suite 313, Oklahoma City, OK 73109; SchwJR{at}integris-health.com (E-mail).

Excessive sleepiness associated with narcolepsy lasts throughout the waking day. The authors conducted two randomized, double-blind studies to compare the efficacy of modafinil once-daily versus split doses in maintaining wakefulness throughout the day. Fifty-six patients received modafinil. The split-dose regimens were significantly more effective than the 200-mg once-daily regimen for sustaining wakefulness in the late afternoon/evening. All modafinil dosing regimens were well tolerated. In patients who experience excessive sleepiness in the late afternoon/evening, despite satisfactory treatment earlier in the day, a split dose of modafinil may promote wakefulness throughout the waking day.

Key Words: Narcolepsy • sleepiness • wakefulness • modafinil • dose-response relationship




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
B. K. Madras, Z. Xie, Z. Lin, A. Jassen, H. Panas, L. Lynch, R. Johnson, E. Livni, T. J. Spencer, A. A. Bonab, et al.
Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 561 - 569.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org